Summary of the quarter
- Q2 has continued along the lines of Q1. Challenging market for customers within the marine segment affecting sales, to some degree offsetting favourable trading in other applications.
- Unfavorable development of FX during Q2, partly mitigated by FX hedge.
- Order intakes for Q2 are up 13% for Steridose and 4% for Seals & Melkerhed in constant currency y-o-y
- During Q2 Velcora Holding AB has repurchased bonds amounting to MSEK 57 of nominal value (10.86% of total issued volume)
Q2 income statement in brief:
| All figures in MSEK | ||
| IFRS | Q2 2016 | Q2 2015 [1] |
| Sales | 74.5 | 72.8 |
| EBITDA | 20.8 | 13.3 |
| Depreciations | -0.9 | -0.5 |
| EBITA | 20.0 | 12.8 |
| Amortizations | -12.7 | -0.2 |
| EBIT | 7.3 | 12.5 |
| Net income | -5.2 | 12.1 |
| Adjusted EBITDA | 22.4 | 21.7 |
Due to changes in group structure, figures are not totally comparable. For further information and the full quarterly report, visit www.velcora.se or contact:
Richard Tuck CEO Velcora Holding AB (publ) Box 120 147 22 Tumba Tel +46 708 78 43 01 www.velcora.se richard.tuck@roplan.com
This information is such that Velcora Holding AB (publ) is obliged to disclose in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was made available for publication on 11 August 2016.
[1] Comparison figures from 2015 refers to Roplan Holding Group, prepared on a pro forma basis
HUG#2034626